ID 3CP9A STANDARD; PRT; 314 AA. DT CONVERTED FROM PDB (SEQRES) 3CP9 DE Vascular endothelial growth factor receptor 2 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.500 CC R-Factor 0.211 FT #SUB 17 831 ARG A 45 859 THR B Protein S 1 FT #SUB 17 831 ARG A 46 860 ALA B Protein A 2 FT #SUB 17 831 ARG A 47 861 THR B Protein B 3 FT #SUB 18 832 ASP A 40 854 PHE B Protein S 1 FT #SUB 18 832 ASP A 46 860 ALA B Protein B 1 FT #SUB 18 832 ASP A 48 862 CYS B Protein B 1 FT #SUB 20 834 LEU A 47 861 THR B Protein B 1 FT #SUB 20 834 LEU A 48 862 CYS B Protein B 5 FT #SUB 21 835 LYS A 38 852 ASP B Protein S 3 FT #SUB 21 835 LYS A 48 862 CYS B Protein A 4 FT #SUB 21 835 LYS A 50 864 THR B Protein S 3 FT #SUB 22 836 LEU A 45 859 THR B Protein S 3 FT #SUB 22 836 LEU A 47 861 THR B Protein S 1 FT #SUB 24 838 LYS A 174 1038 GLU B Protein S 2 FT #SUB 55 869 MET A 45 859 THR B Protein S 1 FT #SUB 58 872 GLU A 44 858 LYS B Protein S 8 FT #SUB 95 909 GLY A 46 860 ALA B Protein B 1 FT #SUB 97 911 PRO A 44 858 LYS B Protein S 1 FT #SUB 97 911 PRO A 45 859 THR B Protein S 3 FT #SUB 99 913 MET A 45 859 THR B Protein S 1 FT #HET 26 840 LEU A 1 501 C19 A S 3 FT #HET 34 848 VAL A 1 501 C19 A S 3 FT #HET 52 866 ALA A 1 501 C19 A S 3 FT #HET 53 867 VAL A 1 501 C19 A B 1 FT #HET 54 868 LYS A 1 501 C19 A A 7 FT #HET 71 885 GLU A 1 501 C19 A S 6 FT #HET 75 889 LEU A 1 501 C19 A S 6 FT #HET 78 892 ILE A 1 501 C19 A S 1 FT #HET 84 898 VAL A 1 501 C19 A S 2 FT #HET 85 899 VAL A 1 501 C19 A S 1 FT #HET 102 916 THR A 1 501 C19 A S 5 FT #HET 103 917 GLU A 1 501 C19 A B 1 FT #HET 104 918 PHE A 1 501 C19 A A 4 FT #HET 105 919 CYS A 1 501 C19 A A 10 FT #HET 162 1026 HIS A 1 501 C19 A S 1 FT #HET 171 1035 LEU A 1 501 C19 A S 6 FT #HET 180 1044 ILE A 1 501 C19 A B 1 FT #HET 181 1045 CYS A 1 501 C19 A A 3 FT #HET 182 1046 ASP A 1 501 C19 A A 7 FT #HET 183 1047 PHE A 1 501 C19 A S 2 FT DISORDER 1 2 FT DISORDER 27 32 FT DISORDER 185 202 CC SEQUENCE 288 AA (ATOM); CC AERLPYDASK WEFPRDRLKL GKPLQVIEAD AFGIDKTATC RTVAVKMLKE GATHSEHRAL CC MSELKILIHI GHHLNVVNLL GACTKPGGPL MVITEFCKFG NLSTYLRSKR NEFVPYKVAP CC EDLYKDFLTL EHLICYSFQV AKGMEFLASR KCIHRDLAAR NILLSEKNVV KICDFGLPLK CC WMAPETIFDR VYTIQSDVWS FGVLLWEIFS LGASPYPGVK IDEEFCRRLK EGTRMRAPDY CC TTPEMYQTML DCWHGEPSQR PTFSELVEHL GNLLQANAQQ DRHHHHHH CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT CC ATOM --AERLPYDASKWEFPRDRLKLGKPL------QVIEADAFGIDKTATCRT CC ************************ ****************** CC SEQRES VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV CC ATOM VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV CC ************************************************** CC SEQRES ITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK CC ATOM ITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK CC ************************************************** CC SEQRES GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD CC ATOM GMEFLASRKCIHRDLAARNILLSEKNVVKICDFG---------------- CC ********************************** CC SEQRES ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE CC ATOM --LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE CC ************************************************ CC SEQRES FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL CC ATOM FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL CC ************************************************** CC SEQRES QANAQQDRHHHHHH CC ATOM QANAQQDRHHHHHH CC ************** SQ SEQUENCE 314 AA; MW; CN; EHAERLPYDA SKWEFPRDRL KLGKPLGRGA FGQVIEADAF GIDKTATCRT VAVKMLKEGA THSEHRALMS ELKILIHIGH HLNVVNLLGA CTKPGGPLMV ITEFCKFGNL STYLRSKRNE FVPYKVAPED LYKDFLTLEH LICYSFQVAK GMEFLASRKC IHRDLAARNI LLSEKNVVKI CDFGLARDIY KDPDYVRKGD ARLPLKWMAP ETIFDRVYTI QSDVWSFGVL LWEIFSLGAS PYPGVKIDEE FCRRLKEGTR MRAPDYTTPE MYQTMLDCWH GEPSQRPTFS ELVEHLGNLL QANAQQDRHH HHHH // ID 3CP9B STANDARD; PRT; 314 AA. DT CONVERTED FROM PDB (SEQRES) 3CP9 DE Vascular endothelial growth factor receptor 2 OS Homo sapiens CC EXPDTA X-RAY DIFFRACTION CC RESOLU 2.500 CC R-Factor 0.211 FT #SUB 38 852 ASP B 21 835 LYS A Protein S 3 FT #SUB 40 854 PHE B 18 832 ASP A Protein S 1 FT #SUB 44 858 LYS B 58 872 GLU A Protein S 8 FT #SUB 44 858 LYS B 97 911 PRO A Protein B 1 FT #SUB 45 859 THR B 17 831 ARG A Protein B 1 FT #SUB 45 859 THR B 22 836 LEU A Protein S 3 FT #SUB 45 859 THR B 55 869 MET A Protein S 1 FT #SUB 45 859 THR B 97 911 PRO A Protein B 3 FT #SUB 45 859 THR B 99 913 MET A Protein B 1 FT #SUB 46 860 ALA B 17 831 ARG A Protein B 2 FT #SUB 46 860 ALA B 18 832 ASP A Protein B 1 FT #SUB 46 860 ALA B 95 909 GLY A Protein S 1 FT #SUB 47 861 THR B 17 831 ARG A Protein A 3 FT #SUB 47 861 THR B 20 834 LEU A Protein S 1 FT #SUB 47 861 THR B 22 836 LEU A Protein S 1 FT #SUB 48 862 CYS B 18 832 ASP A Protein S 1 FT #SUB 48 862 CYS B 20 834 LEU A Protein A 5 FT #SUB 48 862 CYS B 21 835 LYS A Protein B 4 FT #SUB 50 864 THR B 21 835 LYS A Protein S 3 FT #SUB 174 1038 GLU B 24 838 LYS A Protein S 2 FT #HET 34 848 VAL B 2 502 C19 B S 2 FT #HET 52 866 ALA B 2 502 C19 B S 3 FT #HET 53 867 VAL B 2 502 C19 B B 1 FT #HET 54 868 LYS B 2 502 C19 B A 5 FT #HET 71 885 GLU B 2 502 C19 B S 5 FT #HET 75 889 LEU B 2 502 C19 B S 5 FT #HET 84 898 VAL B 2 502 C19 B S 2 FT #HET 85 899 VAL B 2 502 C19 B A 3 FT #HET 102 916 THR B 2 502 C19 B S 4 FT #HET 103 917 GLU B 2 502 C19 B B 1 FT #HET 104 918 PHE B 2 502 C19 B A 4 FT #HET 105 919 CYS B 2 502 C19 B A 9 FT #HET 162 1026 HIS B 2 502 C19 B S 2 FT #HET 171 1035 LEU B 2 502 C19 B S 6 FT #HET 180 1044 ILE B 2 502 C19 B B 1 FT #HET 181 1045 CYS B 2 502 C19 B A 3 FT #HET 182 1046 ASP B 2 502 C19 B A 9 FT #HET 183 1047 PHE B 2 502 C19 B S 2 FT DISORDER 1 4 FT DISORDER 30 31 FT DISORDER 57 59 FT DISORDER 127 132 FT DISORDER 186 202 FT DISORDER 302 314 CC SEQUENCE 269 AA (ATOM); CC RLPYDASKWE FPRDRLKLGK PLGRGGQVIE ADAFGIDKTA TCRTVAVKML ATHSEHRALM CC SELKILIHIG HHLNVVNLLG ACTKPGGPLM VITEFCKFGN LSTYLRSKRN EFVPYKVKDF CC LTLEHLICYS FQVAKGMEFL ASRKCIHRDL AARNILLSEK NVVKICDFGL LPLKWMAPET CC IFDRVYTIQS DVWSFGVLLW EIFSLGASPY PGVKIDEEFC RRLKEGTRMR APDYTTPEMY CC QTMLDCWHGE PSQRPTFSEL VEHLGNLLQ CC !---- CC ALIGNMENT OF SEQRES AND ATOMRES CC SEQRES EHAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT CC ATOM ----RLPYDASKWEFPRDRLKLGKPLGRG--GQVIEADAFGIDKTATCRT CC ************************* ******************* CC SEQRES VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV CC ATOM VAVKML---ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV CC ****** ***************************************** CC SEQRES ITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK CC ATOM ITEFCKFGNLSTYLRSKRNEFVPYKV------KDFLTLEHLICYSFQVAK CC ************************** ****************** CC SEQRES GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD CC ATOM GMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL--------------- CC *********************************** CC SEQRES ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE CC ATOM --LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE CC ************************************************ CC SEQRES FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL CC ATOM FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL CC ************************************************** CC SEQRES QANAQQDRHHHHHH CC ATOM Q------------- CC * SQ SEQUENCE 314 AA; MW; CN; EHAERLPYDA SKWEFPRDRL KLGKPLGRGA FGQVIEADAF GIDKTATCRT VAVKMLKEGA THSEHRALMS ELKILIHIGH HLNVVNLLGA CTKPGGPLMV ITEFCKFGNL STYLRSKRNE FVPYKVAPED LYKDFLTLEH LICYSFQVAK GMEFLASRKC IHRDLAARNI LLSEKNVVKI CDFGLARDIY KDPDYVRKGD ARLPLKWMAP ETIFDRVYTI QSDVWSFGVL LWEIFSLGAS PYPGVKIDEE FCRRLKEGTR MRAPDYTTPE MYQTMLDCWH GEPSQRPTFS ELVEHLGNLL QANAQQDRHH HHHH //